MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jneuroim.2023.578099

Медицинская библиотека · Journal of neuroimmunology · 2023

Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report.

Manzano Giovanna S, Rice Dylan R, Zurawski Jonathan, Jalkh Youmna, Bakshi Rohit, Mateen Farrah J

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND

Familial Mediterranean Fever (FMF) is associated with increased risk of multiple sclerosis (MS). Optimal treatment of patients with comorbid FMF and MS remains uncertain.

CASE: A 28-year-old woman with FMF, treated with colchicine, had symptomatic onset of relapsing remitting MS following four simultaneous vaccines. MRI brain with a 7-Tesla magnet demonstrated several areas of leptomeningeal enhancement with predominant linear, spread/fill and rare nodular patterns. Central vein signs were present in supratentorial white matter lesions. She received four cycles of ocrelizumab and achieved no evidence of disease activity (NEDA-3) at 20 months' follow up.

DISCUSSION: FMF with incident CNS demyelinating disease demonstrated neuroimaging features typical for classic RRMS including the central vein sign and leptomeningeal enhancement. Treatment with B-cell depleting therapy for FMF-MS led to clinical stability and symptomatic improvement at 20 months' follow up. We add to the sparse literature characterizing the course of FMF as a genetic risk factor for CNS demyelinating disease, demonstrating pathognomonic imaging features of MS on 7 T imaging and treatment efficacy with B-cell depletion.

Для цитирования: Manzano Giovanna S, Rice Dylan R, Zurawski Jonathan, Jalkh Youmna, Bakshi Rohit, Mateen Farrah J. Familial Mediterranean Fever and multiple sclerosis treated with ocrelizumab: Case report.. Journal of neuroimmunology. 2023. DOI: 10.1016/j.jneuroim.2023.578099.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.